Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
High neutrophils with low lymphocytes, often described as an elevated neutrophil-to-lymphocyte ratio, is far more commonly linked to acute infection, physical or emotional stress, corticosteroid use, smoking, pregnancy, or recent surgery than to blood cancer. Leukemia and lymphoma can shift white blood cell counts, but they usually bring additional clues such as markedly abnormal total counts, immature cells on the smear, unexplained fever, night sweats, weight loss, easy bruising, or swollen lymph nodes, and no single result can confirm or rule them out. There are several important factors to weigh, including how extreme the numbers are, whether they persist on repeat testing, and which symptoms accompany them, all detailed below.
Because context decides what these values actually mean for you, mapping your full symptom picture is the quickest way to tell whether this deserves prompt evaluation or routine monitoring. Take a free, instant, online symptom check to better understand what may be behind your results and how to approach next steps with your doctor.
Last reviewed for medical accuracy: 09/13/2026
Could high neutrophils and low lymphocytes be an early sign of leukemia or lymphoma?
Understanding your blood work can feel overwhelming. If your results show neutrophils high lymphocytes low, it’s natural to wonder what might be behind those numbers. Below, we explain what this pattern can mean, when it may raise concern for leukemia or lymphoma, and what steps you can take next.
Your white blood cells help fight infection and regulate your immune system. Two major types are:
A shift toward neutrophils high lymphocytes low means your body is producing more neutrophils and fewer lymphocytes than usual.
This blood pattern often reflects a reactive (noncancerous) process. Possible reasons include:
• Bacterial infection or acute inflammation
• Stress responses (physical or emotional stress, surgery, trauma)
• Corticosteroid medications
• Smoking or heavy alcohol use
• Severe illness, burns or tissue damage
• Recovery from chemotherapy or radiation
In these settings, the bone marrow skews production toward neutrophils to fight immediate threats and away from lymphocytes.
Leukemia and lymphoma are cancers of white blood cells. Early on, they can cause abnormal blood counts. However:
High neutrophils with low lymphocytes alone are uncommon as an initial sign of these cancers. But you should discuss with your doctor if you also have:
If you have several of these symptoms alongside blood count changes, further evaluation is warranted.
Even if most cases of neutrophilia (high neutrophils) and lymphopenia (low lymphocytes) aren’t cancer, be alert for:
These can signal more serious conditions, including leukemia, lymphoma or other blood disorders.
If your doctor is concerned, you may be referred for:
Most of these tests are done to rule out or confirm a specific diagnosis.
Seeing abnormal blood counts can be stressful. Keep in mind:
You might also try a quick, self-guided assessment before your appointment. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized insights and prepare questions for your provider.
If you’re worried about your blood counts or any new symptoms, talk to your healthcare provider as soon as possible. Only a medical professional can interpret your results in context and recommend the right next steps. Your health matters—don’t hesitate to reach out for help.
(References)
* Su YL, Kortylewski M. Beclin-1 as a neutrophil-specific immune checkpoint. J Clin Invest. 2019 Dec 2;129(12):5079-5081. doi: 10.1172/JCI132534. PMID: 31657787; PMCID: PMC6877294.
* Hu P, Wang J, Qing Y, Li H, Sun W, Yu X, Hui H, Guo Q, Xu J. FV-429 induces autophagy blockage and lysosome-dependent cell death of T-cell malignancies via lysosomal dysregulation. Cell Death Dis. 2021 Jan 13;12(1):80. doi: 10.1038/s41419-021-03394-4. Epub 2021 Jan 13. PMID: 33441536; PMCID: PMC7806986.
* Haslauer T, Greil R, Zaborsky N, Geisberger R. CAR T-Cell Therapy in Hematological Malignancies. Int J Mol Sci. 2021 Aug 20;22(16). doi: 10.3390/ijms22168996. Epub 2021 Aug 20. PMID: 34445701; PMCID: PMC8396650.
* Krečak I, Holik H, Morić Perić M, Zekanović I, Coha B, Valovičić Krečak M, Gverić-Krečak V, Lucijanić M. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in polycythemia vera. Int J Lab Hematol. 2022 Aug;44(4):e145-e148. doi: 10.1111/ijlh.13786. Epub 2021 Dec 30. PMID: 34970854.
* Carobbio A, Vannucchi AM, De Stefano V, Masciulli A, Guglielmelli P, Loscocco GG, Ramundo F, Rossi E, Kanthi Y, Tefferi A, Barbui T. Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera. Blood Cancer J. 2022 Feb 10;12(2):28. doi: 10.1038/s41408-022-00625-5. Epub 2022 Feb 10. PMID: 35145055; PMCID: PMC8831521.
* Izutsu K, Makita S, Nosaka K, Yoshimitsu M, Utsunomiya A, Kusumoto S, Morishima S, Tsukasaki K, Kawamata T, Ono T, Rai S, Katsuya H, Ishikawa J, Yamada H, Kato K, Tachibana M, Kakurai Y, Adachi N, Tobinai K, Yonekura K, Ishitsuka K. An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma. Blood. 2023 Mar 9;141(10):1159-1168. doi: 10.1182/blood.2022016862. PMID: 36150143; PMCID: PMC10651775.
* Barbui T, Carobbio A, Guglielmelli P, Ghirardi A, Fenili F, Loscocco GG, De Stefano V, Ramundo F, Finazzi MC, Rambaldi A, Vannucchi AM. Neutrophil/lymphocyte ratio identifies low-risk polycythaemia vera patients for early Ropeginterferon alfa-2b therapy. Br J Haematol. 2024 Dec;205(6):2287-2294. doi: 10.1111/bjh.19813. Epub 2024 Oct 7. PMID: 39375955.
* Barbui T, Carobbio A, Ghirardi A, Fenili F, Finazzi MC, Castelli M, Vannucchi AM, Guglielmelli P, Rambaldi A, Gangat N, Tefferi A. Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis. Blood Cancer J. 2024 Nov 6;14(1):195. doi: 10.1038/s41408-024-01176-7. Epub 2024 Nov 6. PMID: 39505848; PMCID: PMC11541874.
* Barbui T, Ghirardi A, Empson V, Fenili F, Loscocco GG, Condorelli A, Iurlo A, Cattaneo D, Rossi E, De Stefano V, Guglielmelli P, Klade C, Gisslinger H, Rambaldi A, Scandura JM, Vannucchi AM. Neutrophil-to-Lymphocyte ratio as surrogate for JAK2(V617F) suppression and event-free survival in polycythemia vera. Blood Cancer J. 2025 Aug 6;15(1):132. doi: 10.1038/s41408-025-01317-6. Epub 2025 Aug 6. PMID: 40770048; PMCID: PMC12328675.
* Pfeifer R, Müller S, Nitsche M, Sohmen M, Kostyra J, Bister A, Bleilevens C, Brauner J, Mekes A, Raasch J, Lukas D, Kopatz J, Al Rawashdeh W, Mues M, Villacorta Hidalgo JA, Huppert V, Assenmacher M, Möker N, Orentas R, Zhang C. Automated manufacturing of clinical-grade BDCA2 CAR NK cells in a closed system for the treatment of blastic plasmacytoid dendritic cell neoplasm. Front Immunol. 2026;17:1761397. doi: 10.3389/fimmu.2026.1761397. Epub 2026 Feb 27. PMID: 41836419; PMCID: PMC12982444.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.